Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma.
Diphenyl difluoroketone (EF24), a molecule having structural similarity to curcumin, was recently reported to inhibit proliferation of various cancer cells significantly. Here we try to determine the effect and mechanism of EF24 on hepatocellular carcinoma. 2 µM EF24 was found to inhibit the prolife...
Main Authors: | Yingjian Liang, Dalong Yin, Limin Hou, Tongsen Zheng, Jiabei Wang, Xianzhi Meng, Zhaoyang Lu, Xuan Song, Shangha Pan, Hongchi Jiang, Lianxin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3162018?pdf=render |
Similar Items
-
Routes towards the concise synthesis of cyclic #alpha#,#alpha#-difluoroketones
by: Thomas, Andrew Colin
Published: (2001) -
Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation
by: Xirui Liu, et al.
Published: (2018-05-01) -
In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.
by: Haitao Liu, et al.
Published: (2012-01-01) -
ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway
by: Yifeng Cui, et al.
Published: (2020-05-01) -
NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathwaysResearch in context
by: Fanzheng Meng, et al.
Published: (2019-06-01)